Heart Care Different for Sexes
Posted on: Monday, 21 March 2005, 06:00 CST
Despite showing signs that they might be having a heart attack, some women aren't treated as aggressively as men in such situations, a new study headed by a University of Cincinnati researcher says.
Using data on 40,912 patients collected from 391 U.S. hospitals, researchers analyzed the diagnosis and treatment of patients whose electrocardiograms indicate a type of heart strain or heart muscle damage.
"We found that women were less likely to receive many of the standard and recommended therapies and procedures for this condition," said lead researcher Dr. Andra L. Blomkalns,of the Department of Emergency Medicine at UC's College of Medicine.
"They've already been diagnosed -- and even after that, they're not being treated (as aggressively as men)."
The analysis took into account that female heart patients tend to be older and sicker than male patients; yet even after making that statistical adjustment, women were less likely to get recommended treatments and tests.
"Across the board with very rare exceptions -- women got fewer medications, fewer therapies -- the blood clotting agents, they got it less," Blomkalns said.
The study was featured last week in the Journal of the American College of Cardiology.
Blomkalns said she believed several factors contribute to the difference in treatment.
"Coronary disease is still considered both by lay public and by physicians as a man's disease," she said. "Most of the initial studies were done with mostly men. Men get it about 10 years earlier than woman, and several studies have shown that men and women present differently." In other words, they have different types of symptoms.
Despite receiving less treatment, women in the study were just as likely to survive as men.
Blomkalns asks, "Might women do even better if they got guideline- recommended therapy?"
The research is the first major study since the American College of Cardiology/American Heart Association put together new guidelines in 2002 for treating heart patients with the type of heart strain in question.
Blomkalns said she hopes the American College of Cardiology/ American Heart Association takes note of the study as part of its national quality improvement initiative.
Source: Cincinnati Post
Related Articles
- The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus(R) Stent in People With Diabetes According to Clinical Data in the Journal of the American College of Cardiology
- Medicure Announces MEND-CABG II Study Results at the American College of Cardiology Annual Scientific Session
- Henry Ford Hospital Heart Physician Installed As President of the American College of Cardiology
- Journal of American College of Cardiology Publishes Positive Findings on Generx Now in Phase 3 for Heart Disease
- Pfizer to Present New Lipitor Data, Including Results From Three Large Atherosclerosis Imaging Trials, at the American College of Cardiology Meeting
- CORRECTING and REPLACING Data Highlighting Cambridge Heart's Non-Invasive HearTwave(R) II System to Be Presented in Late Breaker at American College of Cardiology Meeting
- New Jersey Leads Country on American College of Cardiology's Initiative to Improve Care for Cardiac Arrest Patients
- American Heart Association/American College of Cardiology Scientific Advisory: Annual Flu Shot May Protect Cardiovascular Disease Patients
- Cordis Endovascular, a Division of Cordis Corporation, Supports Peripheral Artery Disease Guidelines Released By the American Heart Association and American College of Cardiology
- Angiomax(R) (Bivalirudin) Recommended for Use in Percutaneous Coronary Interventions in Updated Guidelines From American College of Cardiology and American Heart Association
 |
 |
User Comments (0)
RSS Feeds